|
2023
|
Invention
|
Compositions and methods for the treatment of type 1 diabetes.
Provided herein are compositions ... |
|
2022
|
Invention
|
Genetically modified bacteria stably expressing il-10 and insulin.
The current disclosure provid... |
|
|
Invention
|
Mucoadhesive microorganism.
The present disclosure provides genetically modified microorganisms ... |
|
|
G/S
|
Chemicals, biochemicals and chemical reagents for use in industry and science; chemicals for use ... |
|
2021
|
Invention
|
Compositions and methods for the treatment of type 1 diabetes. Provided herein are compositions a... |
|
2020
|
Invention
|
Polycistronic expression system for bacteria.
The invention relates to polycistronic expression ... |
|
|
Invention
|
Genetically modified bacteria stably expressing il-10 and insulin. Lactococcus lactis) containing... |
|
|
Invention
|
Mucoadhesive microorganism. Lactococcus lactis) contain an exogenous nucleic acid encoding a fusi... |
|
|
Invention
|
Cryoprotectants for freeze drying of lactic acid bacteria. The present invention comprises the di... |
|
2019
|
Invention
|
Modified gram positive bacteria and uses thereof. The present invention relates to gram positive ... |
|
2018
|
Invention
|
Lactococcus. Lactococcus lactis, of secreted immunodominant antigens. |
|
|
Invention
|
Polycistronic expression system for bacteria. The invention relates to polycistronic expression i... |
|
2017
|
Invention
|
Mucoadhesive microorganism. The present disclosure provides genetically modified microorganisms (... |
|
|
Invention
|
Method to improve lactococcus preservation. L. lactis strain, having an internal trehalose concen... |
|
|
Invention
|
Genetically modified bacteria stably expressing il-10 and insulin. The current disclosure provide... |
|
|
G/S
|
Chemicals, biochemicals and reagents for use in industry and science; chemicals for use in bioche... |
|
|
G/S
|
Scientific research; scientific research in the field of bacteriology; bacteriological research; ... |
|
2016
|
Invention
|
Induction of mucosal tolerance to antigens. + and/or IL-10 and/or TGF-β producing regulatory T-ce... |
|
|
Invention
|
Modified gram positive bacteria and uses thereof. Bifidobacterium, with increased stress resistan... |
|
2015
|
Invention
|
Lactococcus preservation. L. lactis strain, having an internal trehalose concentration of at leas... |
|
2013
|
Invention
|
Treatment of immune disease by mucosal delivery of antigens using genetically modified lactococcu... |
|
2012
|
Invention
|
Lactobacillus. Lactococcus lactis, of secreted immunodominant antigens. |
|
2009
|
Invention
|
Method of inducing immune tolerance to type i diabetes. Lactococcus lactis and a anti-CD3 antibody. |
|
|
Invention
|
Reduced colonization of microbes at the mucosa. The invention is in the field of use of engineere... |
|
2008
|
Invention
|
Treatment of immune disease by mucosal delivery of antigens. The present invention relates to the... |
|
|
Invention
|
Lactococcus promoters and uses thereof. Lactococcus and useful as promoters. The invention furthe... |
|
|
Invention
|
Lactococcus promoters and uses thereof. The invention is in the field of molecular biology, and r... |
|
2007
|
G/S
|
Pharmaceutical and veterinary preparations and substances;
dietetic substances for medical use; ... |
|
|
Invention
|
Microbial intestinal delivery of obesity related peptides. The present invention relates to the m... |
|
2006
|
Invention
|
Induction of mucosal tolerance to antigens. The present invention relates to the induction of tol... |
|
|
Invention
|
Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis. Sacchar... |
